• 1. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Introduction to (3-Bromothiophen-2-yl)methanamine hydrochloride (CAS No: 1221723-32-5)

(3-Bromothiophen-2-yl)methanamine hydrochloride, identified by its CAS number 1221723-32-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the class of thiophene derivatives, which are known for their diverse biological activities and potential applications in drug development. The presence of a bromine substituent at the 3-position and an amine group at the 2-position of the thiophene ring imparts unique chemical properties, making it a valuable intermediate in synthetic chemistry and a candidate for further exploration in medicinal chemistry.

The structure of (3-Bromothiophen-2-yl)methanamine hydrochloride consists of a thiophene core, which is a five-membered aromatic ring containing sulfur, bromine, and methylamino functional groups. This arrangement not only contributes to its distinct reactivity but also opens up numerous possibilities for further functionalization. The hydrochloride salt form enhances its solubility in water, facilitating its use in various biochemical assays and pharmaceutical formulations.

In recent years, there has been a growing interest in thiophene-based compounds due to their broad spectrum of biological activities. These activities include antimicrobial, antifungal, anti-inflammatory, and anticancer properties. The bromine atom in the molecule serves as a handle for further chemical modifications, allowing researchers to explore new derivatives with enhanced efficacy and selectivity. For instance, palladium-catalyzed cross-coupling reactions can be employed to introduce additional substituents at different positions of the thiophene ring, leading to novel compounds with tailored biological properties.

One of the most promising applications of (3-Bromothiophen-2-yl)methanamine hydrochloride is in the development of targeted therapeutics. Thiophene derivatives have shown potential in inhibiting specific enzymes and receptors involved in disease pathways. For example, studies have demonstrated that certain thiophene-based compounds can modulate the activity of kinases, which are critical targets in cancer therapy. The amine group in this compound can be further functionalized to create peptidomimetics or small-molecule inhibitors that bind to these targets with high affinity.

Moreover, the hydrochloride salt form of (3-Bromothiophen-2-yl)methanamine hydrochloride offers advantages in terms of stability and bioavailability. This makes it an attractive candidate for preclinical and clinical studies. Researchers have utilized this compound as a building block for synthesizing more complex molecules that exhibit improved pharmacokinetic profiles. The ability to easily modify its structure allows for the optimization of key parameters such as solubility, permeability, and metabolic stability, which are crucial for drug development.

The synthesis of (3-Bromothiophen-2-yl)methanamine hydrochloride involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic substitution reactions on brominated thiophenes followed by functional group transformations to introduce the amine group. Advances in catalytic methods have significantly improved the efficiency of these reactions, making it possible to produce this compound on a larger scale with minimal environmental impact.

In conclusion, (3-Bromothiophen-2-yl)methanamine hydrochloride (CAS No: 1221723-32-5) is a versatile compound with significant potential in pharmaceutical research. Its unique structural features and reactivity make it a valuable tool for developing new drugs targeting various diseases. As research continues to uncover new applications for thiophene derivatives, compounds like this one are likely to play an increasingly important role in the next generation of therapeutics.

• 814255-78-2(N-(4-Bromothien-2-yl)methyl-N-methylamine)
• 61285-33-4(2-THIOPHENEMETHANAMINE, 4-BROMO-N,N,5-TRIMETHYL-)
• 61285-31-2(2-THIOPHENEMETHANAMINE, 3-BROMO-N,N,5-TRIMETHYL-)
• 1086379-44-3((3-bromothiophen-2-yl)methyl(methyl)amine)
• 1909337-80-9((3-Bromo-5-methylthiophen-2-yl)methanamine hydrochloride)
• 1376317-11-1((3-bromothiophen-2-yl)methyl(methyl)amine hydrochloride)
• 771574-41-5((3-Bromothiophen-2-yl)methanamine)
• 479090-38-5((4-Bromothiophen-2-yl)methanamine)
• 1314707-83-9((4-Bromothiophen-2-yl)methanamine hydrobromide)
• 1171697-10-1((4-Bromothiophen-2-YL)methanamine hydrochloride)